Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation.

Tytuł:
Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Chlorpromazine: In Vitro and In Vivo Evaluation.
Autorzy:
Baloch J; Sulaiman Bin Abdullah Aba Al-Khail - Centre for Interdisciplinary Research in Basic Science (SA-CIRBS), International Islamic University, Islamabad 44000, Pakistan. jeand_.
Sohail MF; Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, Lahore 54770, Pakistan. .; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. .
Sarwar HS; Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, Lahore 54770, Pakistan. h_.; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. h_.
Kiani MH; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. .
Khan GM; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. .
Jahan S; Department of Animal Sciences, Quaid-i- Azam University, Islamabad 45320, Pakistan. .
Rafay M; Department of Forester, Range and Wild life management, College f Agriculture and Environmental Sciences, The Islamia University, Bahawalpur 63100, Pakistan. .
Chaudhry MT; Environmental Analytical Lab, NPSL, Pakistan Council of Scientific and Industrial Research (PCSIR), Islamabad 45710, Pakistan. tausif_.
Yasinzai M; Sulaiman Bin Abdullah Aba Al-Khail - Centre for Interdisciplinary Research in Basic Science (SA-CIRBS), International Islamic University, Islamabad 44000, Pakistan. .
Shahnaz G; Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan. .
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2019 May 24; Vol. 55 (5). Date of Electronic Publication: 2019 May 24.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2018- : Basel, Switzerland : MDPI
Original Publication: Kaunas : Lietuvos gydytojų sąjunga
MeSH Terms:
Biological Availability*
Chlorpromazine/*metabolism
Emulsifying Agents/*metabolism
Administration, Oral ; Animals ; Chlorpromazine/pharmacology ; Chlorpromazine/therapeutic use ; Disease Models, Animal ; Drug Delivery Systems/methods ; Drug Delivery Systems/standards ; Emulsifying Agents/therapeutic use ; Rats
References:
Int J Pharm. 2016 Nov 20;513(1-2):211-217. (PMID: 27615708)
Eur J Pharm Sci. 2006 Nov;29(3-4):315-24. (PMID: 16806858)
Eur J Pharm Biopharm. 2011 Sep;79(1):171-80. (PMID: 21303694)
Nano Today. 2017 Aug;15:91-106. (PMID: 29225665)
Sci Rep. 2018 Sep 6;8(1):13304. (PMID: 30190588)
Int J Mol Sci. 2014 Dec 22;15(12):23909-23. (PMID: 25535080)
AAPS PharmSciTech. 2019 Jan 15;20(2):81. (PMID: 30645705)
J Mater Chem B. 2016 Oct 7;4(37):6240-6248. (PMID: 32263636)
J Pharm Pharmacol. 2007 Aug;59(8):1057-64. (PMID: 17725847)
Medicina (Kaunas). 2019 Jan 11;55(1):. (PMID: 30642012)
Mol Pharm. 2015 Feb 2;12(2):504-13. (PMID: 25536306)
Int J Pharm. 2016 Apr 11;502(1-2):151-60. (PMID: 26915809)
Eur J Clin Pharmacol. 1993;45(6):563-9. (PMID: 8157044)
Pharmaceutics. 2016 Jun 27;8(3):. (PMID: 27355963)
Nanomedicine. 2012 Jul;8(5):618-26. (PMID: 21924224)
Contributed Indexing:
Keywords: chlorpromazine; long-chain triglycerides; oral bioavailability; pharmacokinetics; self-nanoemulsifying drug delivery system (SNEDDS); solubility enhancement
Substance Nomenclature:
0 (Emulsifying Agents)
U42B7VYA4P (Chlorpromazine)
Entry Date(s):
Date Created: 20190530 Date Completed: 20191212 Latest Revision: 20231012
Update Code:
20240104
PubMed Central ID:
PMC6572212
DOI:
10.3390/medicina55050210
PMID:
31137751
Czasopismo naukowe
Background and Objectives: Lipid-based self-nanoemulsifying drug delivery systems (SNEDDS) have resurged the eminence of nanoemulsions by modest adjustments and offer many valuable opportunities in drug delivery. Chlorpromazine, an antipsychotic agent with poor aqueous solubility-with extensive first-pass metabolism-can be a suitable candidate for the development of SNEDDS. The current study was designed to develop triglyceride-based SNEDDS of chlorpromazine to achieve improved solubility, stability, and oral bioavailability. Materials and Methods: Fifteen SNEDDS formulations of each short, medium, and long chain, triglycerides were synthesized and characterized to achieve optimized formulation. The optimized formulation was characterized for several in vitro and in vivo parameters. Results: Particle size, zeta potential, and drug loading of the optimized SNEDDS (LCT 14 ) were found to be 178 ± 16, -21.4, and 85.5%, respectively. Long chain triglyceride (LCT 14 ) showed a 1.5-fold increased elimination half-life (p < 0.01), up to 6-fold increased oral bioavailability, and 1.7-fold decreased plasma clearance rate (p < 0.01) compared to a drug suspension. Conclusion: The findings suggest that SNEDDS based on long-chain triglycerides (LCT 14 ) formulations seem to be a promising alternative for improving the oral bioavailability of chlorpromazine.
Competing Interests: The authors declare no conflict of interest.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies